Publication - Advice and guidance

COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech Vaccine National Protocol

Published: 24 March 2021
Topic: Health and social care
ISBN: 9781800048355

This protocol is for the supply and administration of COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech to individuals in accordance with the national COVID-19 vaccination programme.

Supporting documents

5. Clinical condition or situation to which this Protocol applies

COVID-19 mRNA Vaccine BNT162b2 Pfizer/BioNTech is indicated for active immunisation against COVID-19 disease caused by SARS-CoV-2 virus in accordance with Scottish Government COVID-19 immunisation programme and recommendations given in Chapter 14a of the Immunisation Against Infectious Disease: the 'Green Book' COVID-19: the green book, chapter 14a - GOV.UK (www.gov.uk) and Scottish Government CMO letters relating to COVID-19 vaccination.

Contact

Email: Covid19VaccinePolicyMailbox@gov.scot

There is a problem

Thanks for your feedback

Was this helpful?

Yes

Your comments

Your feedback helps us to improve this website. Do not give any personal information because we cannot reply to you directly.

Choose a reason for your feedback

Your comments

Your feedback helps us to improve this website. Do not give any personal information because we cannot reply to you directly.

Yes, but

Choose a reason for your feedback

Your comments

Your feedback helps us to improve this website. Do not give any personal information because we cannot reply to you directly.

Information

5. Clinical condition or situation to which this Protocol applies

Contact

There is a problem